Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 9:54 PM
Ignite Modification Date:
2025-12-25 @ 7:32 PM
NCT ID:
NCT02511132
Group ID:
EG001
Title:
Part 1: Gemicitabine and Docetaxel
Description:
Gemcitabine 675 mg/m2 IV at 10 mg/m2/min D1 and Docetaxel 75 mg/m2 IV starting on D8 and given every 21 days.
Gemcitabine: 675 mg/m2 IV at a rate of 10 mg/m2/min on Day 1 and Day 8 every 21 days
Docetaxel: 75 mg/m2 IV administered on Day 8 and every 21 days
Deaths Number Affected:
8
Deaths Number At Risk:
None
Serious Number Affected:
5
Serious Number At Risk:
8
Other Number Affected:
5
Other Number At Risk:
8
Study:
NCT02511132
Results Section:
NCT02511132
Adverse Events Module:
NCT02511132